JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 34 No. 5 809-811
© 1993 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haubold-Reuter, B. G.
Right arrow Articles by Schulthess, G. K.v.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haubold-Reuter, B. G.
Right arrow Articles by Schulthess, G. K.v.

Bronchogenic Carcinoma Mimicking Metastatic Thyroid Carcinoma

Barbara G. Haubold-Reuter, Ursula Landolt and Gustav K.v. Schulthess

Division of Nuclear Medicine, Department of Medical Radiology and Department of Pathology, University Hospital Zürich, Zürich, Switzerland

Correspondence: For correspondence and reprints contact: G.K.v. Schulthess, MD, PhD, Universitätsspital Zürich, Rämistr. 100, 8091 Zürich, Switzerland.

ABSTRACT

We present a case of a false-positive 131I scan in the follow-up of a patient with papillary thyroid carcinoma, which developed 24 yr after radiation therapy for Hodgkin's disease. In the primary evaluation of a neck mass, histology was typical for a papillary thyroid carcinoma and thyroglobulin staining was positive. After total thyroidectomy, 131I uptake was seen in the hilum and right lung. The initial interpretation of these foci as metastatic disease was not supported by the progressive clinical course despite radioiodine treatment. Hence, repeated bronchial brushings and cytology of the pleural effusion were obtained. These specimens were negative in thyroglobulin staining and positive for synoptophysin, a marker for small-cell bronchial carcinoma. Thereby a small to medium cell undifferentiated bronchial carcinoma was demonstrated, which apparently was actively taking up iodine. In conclusion, an atypical clinical course of a suspected metastatic thyroid carcinoma should lead to a reevaluation of the initial diagnosis to prevent an inappropriate therapeutic regimen.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1993 by the Society of Nuclear Medicine.